Women and Lung Cancer Research and Preventive Services Act of 2024

Bill: 118-hr-4534
Sponsor: full_name: Rep. Boyle, Brendan F. [D-PA-2]
Introduced: 2023-07-11
Policy area: Health
Subjects: Cancer

Cardiovascular and respiratory health

Government studies and investigations

Health care coverage and access

Health promotion and preventive care

Medical research

Medical tests and diagnostic methods

Women's health
Latest action: action_date: 2024-12-17
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2023-07-11
action_desc: Introduced in House
text: <p><b>Women and Lung Cancer Research and Preventive Services Act of </b><b>2023</b></p> <p>This bill requires the Department of Health and Human Services to conduct an interagency review of the status of women and lung cancer. The review must</p> <ul> <li>report on the status of existing research and current knowledge gaps;</li> <li>identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and</li> <li>provide recommendations for a national cancer screening strategy and public education campaign.</li></ul>

action_date: 2024-07-30
action_desc: Reported to House
text: <p><strong>Women and Lung Cancer Research and Preventive Services Act of 2024</strong></p><p>This bill requires the Department of Health and Human Services to conduct an interagency review of lung cancer research, prevention, and awareness with respect to women and underserved populations.</p><p>The review must</p><ul><li>report on the status of existing research and current knowledge gaps;</li><li>identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and</li><li>provide recommendations for a national lung cancer screening strategy and public education campaign.</li></ul>

tv_txt: IIB 118th CONGRESS 2d Session H. R. 4534 IN THE SENATE OF THE UNITED STATES December 17 (legislative day, December 16), 2024 Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions AN ACT To require a review of women and lung cancer, and for other purposes.

1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2024 . 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

Passed the House of Representatives December 16, 2024. Kevin F. McCumber, Clerk.

tv_txt: IB 118th CONGRESS 2d Session H. R. 4534 IN THE HOUSE OF REPRESENTATIVES AN ACT To require a review of women and lung cancer, and for other purposes.

1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2024 . 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

Passed the House of Representatives December 16, 2024. Kevin F. McCumber, Clerk.

tv_txt: IB Union Calendar No. 520 118th CONGRESS 2d Session H. R. 4534 [Report No. 118–622] IN THE HOUSE OF REPRESENTATIVES July 11, 2023 Mr. Boyle of Pennsylvania (for himself, Mr. Fitzpatrick , Ms. Blunt Rochester , Mr. Kilmer , Mr. Carbajal , and Mr. Raskin ) introduced the following bill; which was referred to the Committee on Energy and Commerce July 30, 2024 Additional sponsors: Ms. Pingree , Ms. Wasserman Schultz , Ms. Sewell , Ms. Houlahan , Ms. Moore of Wisconsin , Ms. Dean of Pennsylvania , Mr. Connolly , Ms. Clarke of New York , Ms. Wild , Mr. Rutherford , Mrs. Dingell , Ms. Kuster , Ms. Craig , Mrs. Trahan , Mr. David Scott of Georgia , Ms. Kelly of Illinois , Mr. Bacon , Ms. Stefanik , Mrs. González-Colón , Mr. Lawler , Ms. Castor of Florida , Mr. Ruiz , Mr. Cárdenas , Ms. Norton , Mr. Ciscomani , Mr. Evans , Mr. Doggett , Mrs. Fletcher , Mr. Van Drew , and Mr. Nunn of Iowa July 30, 2024 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed Strike out all after the enacting clause and insert the part printed in italic For text of introduced bill, see copy of bill as introduced on July 11, 2023 A BILL To require a review of women and lung cancer, and for other purposes.

1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2024 . 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

July 30, 2024 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

tv_txt: I 118th CONGRESS 1st Session H. R. 4534 IN THE HOUSE OF REPRESENTATIVES July 11, 2023 Mr. Boyle of Pennsylvania (for himself, Mr. Fitzpatrick , Ms. Blunt Rochester , Mr. Kilmer , Mr. Carbajal , and Mr. Raskin ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require a review of women and lung cancer, and for other purposes.

1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2023 . 2. Findings Congress finds as follows: (1) According to the American Cancer Society, in the United States, approximately 164 women die each day of lung cancer, or about one woman every 8.8 minutes. (2) Lung cancer is the leading cause of cancer death among women. (3) The American Cancer Society estimates that 59,910 women will die of lung cancer in 2023. (4) Studies have shown a higher incidence rate of lung cancer for women who were never smokers compared to men who were never smokers. (5) According to the American Cancer Society, new cases of lung cancer dropped by 3 percent per year in men from 2011 to 2015, while new cases in women only dropped 1.5 percent per year in the same time period. (6) According to the 2014 report, The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014 , the relative risk of developing lung cancer increased tenfold among female smokers between 1959 and 2010. (7) According to the American Cancer Society, approximately 40 percent of lung cancers are adenocarcinoma, a subtype of non-small cell lung cancer, which is the most common type of cancer seen in non-smokers and is more common in women than in men. (8) According to the Environmental Protection Agency, exposure to radon accounts for approximately 21,000 deaths from lung cancer each year and is the second leading cause of lung cancer in nonsmokers. (9) A Government Accountability Office report published on October 22, 2015, called for the National Institutes of Health to do more in evaluating gender differences in research. (10) Additional research strategies, including clinical trials, are necessary to explore the differences in lung cancer risk factors, incidence, and treatment response in women, and to address the disparate impact of lung cancer on women who have never smoked. (11) Lung cancer screening, which can detect lung cancer at its earliest, most curable stage, is a covered service available without cost-sharing for those at high risk. (12) Published peer-reviewed actuarial studies indicate that lung cancer screening individuals at high risk may be cost-effective. (13) The National Framework of Excellence in Lung Cancer Screening and Continuum of Care, launched in 2012, demonstrated that lung cancer screening can be safely and effectively carried out in community hospital settings around the Nation. (14) Information on the impact of lung cancer on women and the importance of early detection should be incorporated into all relevant public health awareness campaigns. 3. Sense of Congress concerning women and lung cancer It is the sense of Congress that— (1) there is a disparate impact of lung cancer on women and, in particular, on women who have never smoked; (2) additional research strategies to explore the differences in women with respect to lung cancer risk factors, incidence, histology, and response to treatment are justified and necessary; (3) the implementation of lung cancer preventive services for women should be accelerated; and (4) the public health agencies of the Federal Government should coordinate public education and awareness programs on the impact of lung cancer on women and the importance of early detection. 4. Interagency review to evaluate and identify opportunities for the acceleration of research on women and lung cancer, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to— (1) research on women and lung cancer; (2) access to lung cancer preventive services; and (3) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to women and lung cancer in all agencies of the Federal Government; (2) specific opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology to improve risk assessment, diagnosis, treatment, and the simultaneous application of other preventive services; (3) opportunities regarding the development of a national lung cancer screening strategy with sufficient infrastructure and personnel resources to expand access to such screening, particularly among underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on women and lung cancer and the importance of early detection of lung cancer. (c) Report Not later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).